Devices › Prosthesis, hip, semi-constrained, metal/ceramic/polymer, cemented or non-porous, uncemented
Device brand name · Mectacer head biolox delta dia 36 12/14-s
Mectacer Biolox Delta Femoral Ball Head: medical device reports filed with FDA
224 reports name it, 2024–2026. Manufacturer given most often on reports: Medacta International. Product code LZO.
- 224
- device reports naming the brand
- 0% of all MAUDE reports · about 108 a year
- 116
- reports, 12 months to August 2026
- 107 in the 12 months before
- 0.4%
- classified as malfunction
- 9.1% across the product code
- 0%
- classified as death, as reported
- 0 reports · not verified by FDA
224 medical device reports received by FDA name the brand "Mectacer Biolox Delta Femoral Ball Head" (mectacer head biolox delta dia 36 12/14-s); the manufacturer given most often on reports is Medacta International; received from June 2024 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
116 reports arrived in the 12 months to August 2026, close to the 107 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (99.6%) and malfunction (0.4%); across all prosthesis, hip, semi-constrained, metal/ceramic/polymer, cemented or non-porous, uncemented reports (product code LZO) death is recorded in 0.2% and malfunction in 9.1%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are device appears to trigger rejection (54.9%), device dislodged or dislocated (28.1%) and fracture (0.9%). The patient problems coded most often are medical device site infection, joint dislocation and implant pain. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 32,865 reports carrying product code LZO. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Device appears to trigger rejection | 123 | 54.9% | 1% |
| Device dislodged or dislocated | 63 | 28.1% | 18.4% |
| Fracturea broken bone | 2 | 0.9% | 6.9% |
| Migrationthe device moved from where it was placed | 1 | 0.4% | 1% |
| Naturally worn | 1 | 0.4% | 2.4% |
| Osseointegration problem | 1 | 0.4% | 2.1% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Medical device site infectioninfection at the device site | 116 | 51.8% |
| Joint dislocationa dislocated joint | 49 | 21.9% |
| Implant pain | 18 | 8% |
| Unequal limb length | 15 | 6.7% |
| Joint laxity | 13 | 5.8% |
| Appropriate clinical signs, symptoms and conditions term/code not available | 6 | 2.7% |
| Painpain, site not specified | 4 | 1.8% |
| Joint impingement | 2 | 0.9% |
| Subluxation | 2 | 0.9% |
| Bacterial infectiona bacterial infection | 1 | 0.4% |
| Hematomaa collection of blood under the skin or in tissue | 1 | 0.4% |
| Inadequate osseointegration | 1 | 0.4% |
| Loss of range of motion | 1 | 0.4% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Mectacer Biolox Delta Femoral Ball Head | Product code LZO | All MAUDE reports |
|---|---|---|---|
| Reports | 224 | 32,865 | 26,136,888 |
| Share of that pool | — | 0.7% | 0% |
| Classified as death, per 1,000 reports | 0 | 2 | 9 |
| Classified as injury | 99.6% | 89.9% | 36.2% |
| Classified as malfunction | 0.4% | 9.1% | 62.3% |
| Filed by the manufacturer | 100% | 98.3% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code LZO
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Delta Cer Head 12/14 36mm +1 5 | 1,191 | 59 | 0% |
| Delta Cer Head 12/14 36mm +5 | 914 | 47 | 0% |
| Delta Cer Head 12/14 32mm +1 | 789 | 39 | 0% |
| Biolox Delta Hip | 549 | 0 | 0% |
| Delta Cer Head 12/14 32mm +5 | 439 | 12 | 0.2% |
| Unknown Head | 2,250 | 103 | 0.7% |
| BIOLOX Delta | 369 | 255 | 0% |
| Delta Cer Head 12/14 36mm +8 5 | 362 | 22 | 0% |
| UNK Hip Femoral Stem Corail | 523 | 56 | 0.8% |
| Trinity | 673 | 60 | 0.1% |
| Dlt Ts Cer Hd 12/14 36mm +1 5 | 310 | 2 | 0% |
| Modular Dual Mobility Insert | 249 | 6 | 0% |
| Delta Cer Head 12/14 28mm +1 5 | 232 | 13 | 0% |
| Dlt Ts Cer Hd 12/14 36mm +5 0 | 296 | 7 | 0.3% |
| Unknown Stem | 1,857 | 84 | 0.5% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Mectacer Biolox Delta Femoral Ball Head reports
How many FDA reports name Mectacer Biolox Delta Femoral Ball Head?
224 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 116 in the latest 12 months.
What kinds of events are reported?
injury (99.6%) and malfunction (0.4%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
device appears to trigger rejection (54.9%), device dislodged or dislocated (28.1%), fracture (0.9%), migration (0.4%) and naturally worn (0.4%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Mectacer Biolox Delta Femoral Ball Head was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.